跳至主要内容
临床试验/PACTR202107466690046
PACTR202107466690046已完成3 期

Early Prediction and Prevention of Asymptomatic Cardiac Insult in Pediatric Patients with Lysosomal Storage Diseases: (Evaluation of CoQ10 as a Cardioprotective Drug)

Faculty of medecine of Tanta university0 个研究点目标入组 20 人开始时间: 2021年6月29日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Year(s) 至 5 Year(s)(—)
性别
All

入选标准

  • Pediatric patients with Lysosomal storage disease aged from 1 to 18 years diagnosed by enzyme assay.

排除标准

  • Lysosomal storage disease patients with diabetes mellitus, cancer and bronchial asthma as these diseases may cause cardiac diseases and may alter patient's response to the used drug and may affect the level of the studied biomarkers.

研究者

发起方
Faculty of medecine of Tanta university

相似试验